Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using 18F-FDG PET/CT

S Ueda, N Yoshizawa, T Shigekawa… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Diffuse optical spectroscopic imaging (DOSI) is used as an indicator of tumor blood volume
quantified by tissue hemoglobin concentrations. We aimed to determine whether early …

A comparison of near-infrared diffuse optical imaging and 18F-FDG PET/CT for the early prediction of breast cancer response to neoadjuvant chemotherapy

S Jiang, BW Pogue - Journal of Nuclear Medicine, 2016 - Soc Nuclear Med
In recent years, neoadjuvant chemotherapy (NAC) before surgery has become the standard
of care for patients who present with advanced breast cancers or multiple lesions, in order to …

Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer

H Soliman, A Gunasekara, M Rycroft, J Zubovits… - Clinical cancer …, 2010 - AACR
Purpose: Functional imaging with tomographic near-infrared diffuse optical spectroscopy
(DOS) can measure tissue concentration of deoxyhemoglobin (Hb), oxyhemoglobin (HbO2) …

Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients

EA Lim, JE Gunther, HK Kim, M Flexman… - Breast cancer research …, 2017 - Springer
Purpose Breast cancer (BC) patients who achieve a favorable residual cancer burden (RCB)
after neoadjuvant chemotherapy (NACT) have an improved recurrence-free survival. Those …

Predicting responses to neoadjuvant chemotherapy in breast cancer: ACRIN 6691 trial of diffuse optical spectroscopic imaging

BJ Tromberg, Z Zhang, A Leproux, TD O'Sullivan… - Cancer research, 2016 - AACR
The prospective multicenter ACRIN 6691 trial was designed to evaluate whether changes
from baseline to mid-therapy in a diffuse optical spectroscopic imaging (DOSI)–derived …

[HTML][HTML] Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens

A Tank, HM Peterson, V Pera, S Tabassum… - Breast cancer …, 2020 - Springer
Background Breast cancer patients with early-stage disease are increasingly administered
neoadjuvant chemotherapy (NAC) to downstage their tumors prior to surgery. In this setting …

Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography

Q Zhu, PA DeFusco, A Ricci Jr, EB Cronin, PU Hegde… - Radiology, 2013 - pubs.rsna.org
Purpose To assess initial breast tumor hemoglobin (Hb) content before the initiation of
neoadjuvant chemotherapy, monitor the Hb changes at the end of each treatment cycle, and …

Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment

S Jiang, BW Pogue, PA Kaufman, J Gui, M Jermyn… - Clinical Cancer …, 2014 - AACR
Purpose: To determine whether pretreatment biomarkers obtained from diffuse optical
spectroscopic tomographic (DOST) imaging predicts breast tumor response to neoadjuvant …

Changes in diffuse optical tomography images during early stages of neoadjuvant chemotherapy correlate with tumor response in different breast cancer subtypes

ML Altoe, K Kalinsky, A Marone, HK Kim, H Guo… - Clinical Cancer …, 2021 - AACR
Purpose: This study's primary objective was to evaluate the changes in optically derived
parameters acquired with a diffuse optical tomography breast imaging system (DOTBIS) in …

Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient

AE Cerussi, VW Tanamai, RS Mehta, D Hsiang… - Academic radiology, 2010 - Elsevier
RATIONALE AND OBJECTIVES: Imaging tumor response to neoadjuvant chemotherapy in
vivo offers unique opportunities for patient care and clinical decision-making. Detailed …